Published in J Cardiovasc Pharmacol on May 16, 1985
Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest (1995) 1.33
Signal transduction by cGMP in heart. Basic Res Cardiol (1992) 1.09
Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol (1984) 1.57
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation (1983) 1.51
Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. J Am Coll Cardiol (1990) 1.44
Nonrebreathing anesthetic systems in small animal practice. J Am Vet Med Assoc (2000) 1.39
Cardiovascular effects of thoracic compression in horses subjected to euthanasia. Equine Vet J (1993) 1.39
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol (1998) 1.39
Simultaneous evaluation of left ventricular end-systolic pressure-volume ratio and time constant of isovolumic pressure decline in dogs exposed to equivalent MAC halothane and isoflurane. Anesthesiology (1988) 1.38
Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anesthetized with thiamylal and halothane. Am J Vet Res (1975) 1.33
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol (1986) 1.32
Human myocardial histologic characteristics in congestive heart failure. Circulation (1983) 1.23
Analysis of troponin-tropomyosin binding to actin. Troponin does not promote interactions between tropomyosin molecules. J Biol Chem (1992) 1.22
Control of an outbreak of salmonellosis caused by drug-resistant Salmonella anatum in horses at a veterinary hospital and measures to prevent future infections. J Am Vet Med Assoc (1996) 1.19
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation (1984) 1.18
Response of failing canine and human heart cells to beta 2-adrenergic stimulation. Circulation (1995) 1.18
Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation (1986) 1.14
Captopril in primary pulmonary hypertension. Circulation (1983) 1.12
Atrial fibrillation in cows: clinical findings and therapeutic considerations. J Am Vet Med Assoc (1983) 1.10
Alpha-adrenoceptor stimulation in the presence of halothane: effects on impulse propagation in cardiac Purkinje fibers;. Anesth Analg (1991) 1.09
Modulation of divalent cation-activated chloride ion currents. Br J Pharmacol (1988) 1.09
A review of laboratory animal anesthesia with chloral hydrate and chloralose. Lab Anim Sci (1993) 1.09
Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther (1982) 1.08
Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol (1986) 1.07
Effects of halothane on impulse propagation in Purkinje fibers and at Purkinje-muscle junctions: relationship of Vmax to conduction velocity. Anesth Analg (1991) 1.07
An investigation into the mechanisms of inhibition of calcium channel currents in cultured sensory neurones of the rat by guanine nucleotide analogues and (-)-baclofen. Br J Pharmacol (1989) 1.06
Rat brain protein kinase C: purification, antibody production, and quantification in discrete regions of hippocampus. J Neurochem (1989) 1.05
Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J Immunol (1992) 1.05
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med (1982) 1.04
Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses. Am J Vet Res (1977) 1.03
The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Pharmacotherapy (1986) 1.02
Drugs five years later. Dobutamine. Ann Intern Med (1983) 1.02
Caudal epidural analgesia induced by xylazine administration in cows. Am J Vet Res (1990) 1.02
Cardiovascular effects of xylazine and detomidine in horses. Am J Vet Res (1991) 1.01
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. Ann Intern Med (1981) 1.01
Mechanisms of gastrointestinal ischemia-reperfusion injury and potential therapeutic interventions: a review and its implications in the horse. J Vet Intern Med (1995) 0.99
Diagnosis and treatment of cardiac arrhythmias. Vet Clin North Am Equine Pract (1985) 0.97
Estimation of cardiac output in the horse by thermodilution techniques. Am J Vet Res (1976) 0.97
Assessment of the cardiovascular and lymphatic systems. Vet Clin North Am Food Anim Pract (1992) 0.96
Anesthesia and the heart. J Am Vet Med Assoc (1977) 0.95
Cardiopulmonary effects of position in conscious cattle. Am J Vet Res (1990) 0.95
Molecular polarity in tropomyosin-troponin T co-crystals. Biophys J (1997) 0.94
Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol (1987) 0.93
Hemodynamic responses in halothane-anesthetized horses given infusions of dopamine or dobutamine. Am J Vet Res (1985) 0.93
Adverse effects of administration of propofol with various preanesthetic regimens in dogs. J Am Vet Med Assoc (1993) 0.93
Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation (1989) 0.91
Paratuberculosis (Johne's disease) in cattle and other susceptible species. J Vet Intern Med (2012) 0.91
Evaluation of a portable clinical analyzer in a veterinary hospital setting. J Am Vet Med Assoc (1998) 0.91
Effect of xylazine on indices of myocardial contractility in the dog. Am J Vet Res (1977) 0.91
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol (1985) (1985) 0.91
Lung sounds in cattle, horses, sheep and goats. Can Vet J (1986) 0.91
Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells. Placenta (2001) 0.90
The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J (1983) 0.90
Accuracy of noninvasive oxyhemoglobin saturation, end-tidal carbon dioxide concentration, and blood pressure monitoring during experimentally induced hypoxemia, hypotension, or hypertension in anesthetized dogs. Am J Vet Res (1998) 0.90
Mural blood flow distribution in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res (1995) 0.90
Cardiac evaluation of mitoxantrone. Cancer Treat Rep (1983) 0.90
Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Circulation (1986) 0.89
Morphologic and functional characteristics of the heart in Friedreich's ataxia. Am J Med (1987) 0.89
Early changes in human myocardial nuclei after doxorubicin. Cancer (1983) 0.88
Neutrophil accumulation in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res (1994) 0.88
The effect of left atrial histology and dimension on P wave morphology. J Electrocardiol (1983) 0.88
Identification of functional platelet-activating factor receptors in Raji lymphoblasts. J Immunol (1989) 0.88
Atrial fibrillation in halothane- and isoflurane-anesthetized dogs. Am J Vet Res (1990) 0.88
Barbiturate anesthesia in greyhound and mixed-breed dogs: comparative cardiopulmonary effects, anesthetic effects, and recovery rates. Am J Vet Res (1986) 0.87
Cardiopulmonary effects of narcotic agonists and a partial agonist in horses. Am J Vet Res (1978) 0.87
Cardiorespiratory effects of sevoflurane, isoflurane, and halothane anesthesia in horses. Am J Vet Res (1998) 0.87
Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration. Cancer Treat Rep (1982) 0.87
Effects of atropine on cardiac rate and rhythm in dogs. J Am Vet Med Assoc (1978) 0.87
Xylazine and tiletamine-zolazepam anesthesia in horses. Am J Vet Res (1989) 0.86
Doxorubicin cardiotoxicity. Cancer Treat Rev (1982) 0.86
Change of inhalation anesthetic agents for management of ventricular premature depolarizations in anesthetized cats and dogs. J Am Vet Med Assoc (1984) 0.86
Pharmacodynamic and pharmacokinetic properties of diazepam in horses. Am J Vet Res (1982) 0.86
Cardiovascular effects of medetomidine, detomidine and xylazine in horses. J Vet Med Sci (2000) 0.86
Metabolic alkalosis with paradoxic aciduria in cattle. J Am Vet Med Assoc (1980) 0.86
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. Am J Cardiol (1980) 0.86
Hemodynamic and respiratory effects of a xylazine-acetylpromazine drug combination in horses. Am J Vet Res (1979) 0.86
Cardiorespiratory effects of the intravenous administration of tiletamine-zolazepam to dogs. Vet Surg (1989) 0.86
Blood gas values during intermittent positive pressure ventilation and spontaneous ventilation in 160 anesthetized horses positioned in lateral or dorsal recumbency. Vet Surg (1995) 0.85
Rest and exercise cardiovascular effects of terazosin in congestive heart failure. Am J Cardiol (1990) 0.85
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther (1984) 0.85
Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses. Am J Vet Res (1985) 0.85
Acid-base and electrolyte disturbances in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc (1982) 0.85
Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve. Am J Cardiol (1984) 0.84
Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs. Am J Vet Res (1995) 0.84
Comparison of anion gap and strong ion gap as predictors of unmeasured strong ion concentration in plasma and serum from horses. Am J Vet Res (1998) 0.84
Role of ferric iron in platelet lipoxygenase activity. Biochem Biophys Res Commun (1980) 0.84
Evaluation of xylazine, guaifenesin, and ketamine hydrochloride for restraint in horses. Am J Vet Res (1978) 0.84
Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests. Am J Med (1982) 0.84
Renal tubular function in horses during submaximal exercise. Am J Physiol (1991) 0.84
Drug-induced conditioning in congestive heart failure. Circulation (1982) 0.84
Reiter's aortitis with pericardial fluid, heart block and neurologic manifestations. J Rheumatol (1979) 0.84
Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. Am J Vet Res (1985) 0.83
Cardiopulmonary effects of butorphanol tartrate in horses. Am J Vet Res (1981) 0.83
Histopathologic evidence of reperfusion injury in the large colon of horses after low-flow ischemia. Am J Vet Res (1994) 0.83
Cardiorespiratory effects of the intravenous administration of tiletamine-zolazepam to cats. Vet Surg (1989) 0.83
Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs. Am J Vet Res (2000) 0.83
Long-term benefit of dobutamine in patients with congestive cardiomyopathy. Am Heart J (1980) 0.83
Pharmacokinetics of detomidine administered to horses at rest and after maximal exercise. Equine Vet J (2009) 0.83
Morbidity of endomyocardial biopsy in cardiomyopathy. Am J Cardiol (1991) 0.83
The effects of medetomidine on cardiac contractility in autonomically blocked dogs. Vet Surg (1995) 0.83